CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −540 | $16.43 | $9K | 25,634 |
| 2018-09-07 | Zhen Marianne Chief Accounting Officer | Grant or award | +1,779 | 23,347 | ||
| 2018-08-21 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Sale | −8,000 | $14.11 | $113K | 285,479 |
| 2018-08-21 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Sale | −8,504 | $14.12 | $120K | 247,767 |
| 2018-08-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −536 | $14.08 | $8K | 23,568 |
| 2018-08-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −5,680 | $14.08 | $80K | 293,479 |
| 2018-08-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −3,089 | $14.08 | $43K | 256,271 |
| 2018-05-21 | dEsparbes Eric SVP and CFO | Sale | −5,808 | $14.40 | $84K | 373,081 |
| 2018-05-21 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Sale | −8,000 | $14.40 | $115K | 299,159 |
| 2018-05-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −7,901 | $14.59 | $115K | 376,965 |
| 2018-05-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −4,682 | $14.59 | $68K | 305,235 |
| 2018-05-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −3,089 | $14.59 | $45K | 259,360 |
| 2018-04-24 | Odysseas Kostas D Director | Grant or award | +14,249 | 28,762 | ||
| 2018-04-24 | Haimovitz Jules Director | Grant or award | +14,249 | 36,966 | ||
| 2018-04-24 | Schlesinger Sarah J. Director | Grant or award | +14,249 | 24,766 | ||
| 2018-04-24 | DiPaolo Mark Director | Grant or award | +14,249 | 24,766 | ||
| 2018-04-24 | Bickerstaff George Director | Grant or award | +14,249 | 28,762 | ||
| 2018-03-02 | dEsparbes Eric Interim PEO, SVP and CFO | Grant or award | +93,056 | 384,866 | ||
| 2018-03-02 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Grant or award | +74,444 | 309,917 | ||
| 2018-03-02 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Grant or award | +74,444 | 262,017 |
Page 11 of 15 · 297 trades